VIDEO: MEK/BRAF combo puts brakes on BRAF-mutated advanced melanoma progression

MADRID – Combining the investigational MEK inhibitor cobimetinib with the BRAF inhibitor vemurafenib nearly halved the risk of progression in previously untreated patients with BRAF-mutated advanced...